Speciality: Oncology
Description:
Welcome to this insightful overview on the incidence of lung cancer, with a special focus on ALK-rearranged NSCLC, presented by the esteemed Dr. Vamshi Krishna M. In this video, Dr. Vamshi provides a comprehensive understanding of the prevalence, risk factors, and key statistics associated with lung cancer, while delving deeper into the unique characteristics of ALK-rearranged non-small cell lung cancer (NSCLC). His expertise sheds light on why this specific genetic alteration is critical in diagnosis and treatment, offering valuable insights for medical professionals and researchers alike.
Dr. Vamshi Krishna M further explores the diagnostic challenges and advancements in detecting ALK rearrangements, emphasizing the importance of targeted therapies in improving patient outcomes. He discusses the latest research, treatment protocols, and the evolving landscape of precision medicine in managing ALK-positive NSCLC. This discussion serves as an essential resource for oncologists, pulmonologists, and healthcare practitioners seeking to enhance their knowledge in this specialized area of lung cancer care.
We hope this video provides you with a deeper understanding of ALK-rearranged NSCLC and its significance in modern oncology. Stay tuned for more expert-led discussions and updates on cutting-edge advancements in cancer research and treatment. Don’t forget to watch till the end and subscribe for future informative sessions!
See More Webinars @ Hidoc Webinars
1.
Limited Benefit from New Drugs; Significant Increase in Drug Prices; AI Boost for Mammo Results.
2.
Researchers use AI to monitor side effects of chemotherapy and support families dealing with pediatric cancer.
3.
Prior authorizations draining time, energy from many cancer patients
4.
Team finds broken 'brake' on cancer mutation machine.
5.
Ketamine plus psychotherapy for "excellent" PTSD
1.
The Oncologist’s Edge: Tools, Trials, and Tech Transforming Treatment
2.
Digital Oncology: How Remote Monitoring and Mobile Health Are Transforming Cancer Care
3.
AI-Powered Case Studies in Oncology: Elevating Clinical Influence Through Real-World Data
4.
Chronic Cancer Survivorship: Managing Long-Term Outcomes with Precision Care
5.
Unlocking the Potential of Glofitamab: A Novel Treatment for Cancer
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
2.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- Further Discussion on A New Perspective
3.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part III
4.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
5.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation